Kolon Biotech Inc. is a South Korean cell and gene therapy CDMO, part of the Kolon Group. They operate 17,000 sqm of facilities designed for both development and GMP manufacturing of cell and gene therapy products. Their B1 plant supports multiple simultaneous products and development projects, while B2 is optimized for mass production targeting global markets with flexible customization. Kolon Biotech is FDA-registered (FEI 3019016602) for analysis, API manufacture, labeling, manufacturing, and packaging. They offer end-to-end CDMO services aimed at shortening time-to-market, including a 2D Automated Closed Platform for large-scale adherent cell manufacturing.
cell therapy CDMO, gene therapy CDMO, GMP manufacturing, 2D automated closed platform for adherent cells, regulatory support (IND to BLA), process development
1 site worldwide
No reviews available yet.
No documents available.